✓
Open
7 Aug 2017
✓
Close
10 Aug 2017
3
Allotment
—
✓
Listing
Tue, Aug 22, 2017
Price Band
₹71 to ₹72
Issue Size
19,76,000 shares (agg. up to ₹14 Cr)
Lot Size
1,600 Shares
Listing Date
Tue, Aug 22, 2017
✦ AI Insight
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 1.60x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Mar 2017 | 31 Mar 2016 | 31 Mar 2015 |
|---|---|---|---|
| Assets | 44.65 | 49.41 | 45.80 |
| Total Income | 67.11 | 69.89 | 98.82 |
| Profit After Tax | 0.66 | -0.03 | 0.16 |
| NET Worth | 3.87 | 3.20 | 3.24 |
| Reserves and Surplus | 0.87 | 2.70 | 2.74 |
| Total Borrowing | 21.17 | 19.76 | 24.04 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Zota Health Care Ltd. | SME | ₹58.50 Cr | ₹125 | null | ₹125.60 | +0.48% | ₹1,277.40 (-4.03%) |
| Sakar Healthcare Ltd. | SME | ₹14.81 Cr | ₹50 | null | ₹52.15 | +4.30% | ₹837.25 (-4.72%) |
| Eris Lifesciences Ltd. | Mainboard | ₹1,740.49 Cr | ₹603 | null | ₹601.50 | -0.25% | ₹1,440.60 (-1.95%) |
| Laurus Labs Ltd. | Mainboard | ₹1,330.51 Cr | ₹428 | null | ₹480.40 | +12.24% | ₹1,577.80 (-0.96%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Working Capital Requirement | 13.00 |
| 2 | General corporate purposes | 0.63 |
About Vaishali Pharma IPO
Incorporated in 2008, Vaishali Pharma Ltd is a pharmaceutical company engaged in pharmaceutical formulations, APIs, surgical products, veterinary supplements, herbal & nutraceutical products. They are operating both in domestic and export markets. They have also established office in the Vietnam. At present they are supplying in around 10 countries.In domestic markets, they are majorly into trading of APIs whereas in export markets, they are into trading and marketing of APIs, formulations, surgical products and others. Recently they have applied for 186 registrations in 13 countries for some of their products and received 71 approvals from 7 countries.They export Formulations, Surgical & APIs to Kenya, Sri Lanka, Russia, DR Congo, Myanmar, Tajikistan, Bangladesh, Kazakhstan, Cameroon, Jordan, Burkina -Faso, Nicaragua, Senegal, Pakistan, Ukraine, Yemen, Cambodia, Turkey, Congo, Zimbabwe, Ethiopia, Tanzania, Vietnam, Armenia, Costa Rica, Nigeria, C.A.R. and Guinea-Bissau.+ Read More
Contact Details
Vaishali Pharma Ltd. Address706 to 709 7th FloorAravali Business CentreBorivali (West)Mumbai, Maharashtra, 400092+ 91-22-28928833investor@vaishalipharma.comVisit Website